Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Miyamoto

Showing results (171-180 of 219) with videos related to

Pageof 22
Sort By:
Japanese Journal of Clinical Oncology|January 28, 2021
Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosisNobuyasu Awano, Takehiro Izumo, Minoru Inomata, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
Transwell Culture with Adipose Tissue-Derived Stem Cells and Fertilized Eggs Mimics the In Vivo Development of Fertilized Eggs to Blastocysts in the Fallopian Tube: An Animal StudyToyofumi Hirakawa, Kazuhiko Nakabayashi, Noriko Ito, et al.
Radiology Case Reports|June 17, 2026
Two case reports of ovarian clear cell carcinoma with central necrosis representing a mille-feuille-like appearance on contrast-enhanced MRINobuyuki Takeyama, Yasuo Ueda, Yuki Tashiro, et al.
Palliative & Supportive Care|March 5, 2021
Comparison between patient-reported and clinician-reported outcomes: Validation of the Japanese version of the Integrated Palliative care Outcome Scale for staffHiroki Sakurai, Mitsunori Miyashita, Tatsuya Morita, et al.
Cancer Medicine|July 26, 2014
Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinomaKohei Miyata, Fusanori Yotsumoto, Sung Ouk Nam, et al.
Anticancer Research|August 2, 2019
Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial CancerDaisuke Miyahara, Fusanori Yotsumoto, Toyofumi Hirakawa, et al.
Cancers|March 3, 2021
Rabdosianone I, a Bitter Diterpene from an Oriental Herb, Suppresses Thymidylate Synthase Expression by Directly Binding to ANT2 and PHB2Motoki Watanabe, Yasumasa Yamada, Yoichi Kurumida, et al.
Cancer Research|August 18, 2004
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapyShingo Miyamoto, Michinari Hirata, Ayano Yamazaki, et al.
Carcinogenesis|October 21, 2006
A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesisHiroki Makita, Michihiro Mutoh, Takayuki Maruyama, et al.
Cancer Letters|November 14, 2021
Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinomaShingo Miyamoto, Yoshiko Nagano, Makoto Miyazaki, et al.
Pageof 22

Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
Japanese Journal of Clinical Oncology|January 28, 2021
Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosisNobuyasu Awano, Takehiro Izumo, Minoru Inomata, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
Transwell Culture with Adipose Tissue-Derived Stem Cells and Fertilized Eggs Mimics the In Vivo Development of Fertilized Eggs to Blastocysts in the Fallopian Tube: An Animal StudyToyofumi Hirakawa, Kazuhiko Nakabayashi, Noriko Ito, et al.
Radiology Case Reports|June 17, 2026
Two case reports of ovarian clear cell carcinoma with central necrosis representing a mille-feuille-like appearance on contrast-enhanced MRINobuyuki Takeyama, Yasuo Ueda, Yuki Tashiro, et al.
Palliative & Supportive Care|March 5, 2021
Comparison between patient-reported and clinician-reported outcomes: Validation of the Japanese version of the Integrated Palliative care Outcome Scale for staffHiroki Sakurai, Mitsunori Miyashita, Tatsuya Morita, et al.
Cancer Medicine|July 26, 2014
Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinomaKohei Miyata, Fusanori Yotsumoto, Sung Ouk Nam, et al.
Anticancer Research|August 2, 2019
Clinical Features of Recurrence in Patients Without Residual Tumour in Endometrial CancerDaisuke Miyahara, Fusanori Yotsumoto, Toyofumi Hirakawa, et al.
Cancers|March 3, 2021
Rabdosianone I, a Bitter Diterpene from an Oriental Herb, Suppresses Thymidylate Synthase Expression by Directly Binding to ANT2 and PHB2Motoki Watanabe, Yasumasa Yamada, Yoichi Kurumida, et al.
Cancer Research|August 18, 2004
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapyShingo Miyamoto, Michinari Hirata, Ayano Yamazaki, et al.
Carcinogenesis|October 21, 2006
A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesisHiroki Makita, Michihiro Mutoh, Takayuki Maruyama, et al.
Cancer Letters|November 14, 2021
Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinomaShingo Miyamoto, Yoshiko Nagano, Makoto Miyazaki, et al.
Pageof 22